Immune checkpoint therapy appears to be promising and is rapidly expanding to include a large variety of cancers.
No takes yet. Share an insight, caveat, or question.
Akhtar et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: